Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers

BACKGROUND/OBJECTIVE: Given the poor overall survival (OR) and progression-free survival (PFS) rates for lung cancers managed with surgical resection, there is a need to identify the prognostic markers that would improve the risk stratification of patients with operable lung cancer to inform treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Daniel, Perry, Luke A., Renouf, Jesse, Vodanovich, Domagoj, Hong Lee, Adele Hwee, Dimiri, Jahan, Wright, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109682/
https://www.ncbi.nlm.nih.gov/pubmed/34012481
http://dx.doi.org/10.4103/atm.ATM_382_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109682/
https://www.ncbi.nlm.nih.gov/pubmed/34012481
http://dx.doi.org/10.4103/atm.ATM_382_20

Ejemplares similares